Federal hemp product ban advances in Congress (Newsletter: June 6, 2025)

*Marijuana puts “pressure” on alcohol sales; CO gov signs cannabis &
psychedelics bills; OH legalization amendments; Legal cannabis & hotel
profits*

Subscribe to receive Marijuana Moment’s newsletter in your inbox every
weekday morning. It’s the best way to make sure you know which cannabis
stories are shaping the day.
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

*Your support makes Marijuana Moment possible…*

*Your good deed for the day:* donate to an independent publisher like
Marijuana Moment and ensure that as many voters as possible have access to
the most in-depth cannabis reporting out there.

Support our work at https://www.patreon.com/marijuanamoment

*/ TOP THINGS TO KNOW*

The House Appropriations Subcommittee on Agriculture, Rural Development,
Food and Drug Administration, and Related Agencies approved a bill with
provisions to ban most consumable hemp-derived cannabinoid products that
were federally legalized during the first Trump administration.

Colorado Gov. Jared Polis (D) signed bills to streamline marijuana
regulations, allow mass pardons for prior psychedelics convictions and
revise how cannabis revenue is allocated.

The Ohio House Judiciary Committee heard hours of public testimony against
a bill to revise the state’s voter-approved marijuana legalization law,
with members signaling that further changes to the plan are on the way in
response to those concerns.

The Nevada legislature passed a resolution calling on the federal
government to “reschedule psilocybin, psilocin, DMT, ibogaine, mescaline
and MDMA to a schedule that better reflects the therapeutic value, low
potential for abuse and safety.”

A federal judge denied the Oregon Health Authority’s motion to dismiss a
lawsuit claiming that the state’s psilocybin services program violates the
Americans With Disabilities Act by discriminating against homebound
patients who can’t travel to designated service centers.

The CEO of Jack Daniel’s maker Brown–Forman Corporation said growing use of
cannabis as an alternative to alcohol is putting “pressure” on the spirits
industry—with the company noting that “further legalization of marijuana”
is among the “risks and uncertainties” for the sector.

A new study shows that after cannabis legalization, “hotel revenue
increases by 25.2%…with the effect continuing to grow even six years after
legalization”—highlighting “the potential long-term economic advantages of
recreational marijuana.”

- “Recreational marijuana dispensaries could become attractions that
entice travelers to visit places they might not otherwise explore.”

*/ FEDERAL*

The Drug Enforcement Administration promoted an article linking marijuana
to mental health challenges.

The Food and Drug Administration sent a warning letter to Latro Inc. about
products it says contain delta-8 THC.

Rep. Andy Harris (R-MD) said he is “overjoyed” that President Donald Trump
included a continued ban on Washington, D.C. legalizing recreational
marijuana sales in his budget request.

Rep. Jamie Raskin (D-MD) reacted to former Department of Government
Efficiency head Elon Musk criticizing a Republican-led budget bill by
tweeting, “Now even someone on ketamine, mushrooms and Ecstasy can see it.”

*/ STATES*

New York Gov. Kathy Hochul (D) nominated a member of the Cannabis Control
Board to take over as its new chair.

North Carolina Gov. Josh Stein (D) tweeted, “I look forward to working with
the General Assembly to address existing loopholes on cannabis sales that
allows teens to buy intoxicating THC here in NC and come up with
thoughtful, comprehensive solutions to allow adult use and keep our
children safe.”

Connecticut’s attorney general cheered the passage of legislation targeting
illegal cannabis and tobacco sales.

The Massachusetts House of Representatives passed a bill to overhaul the
Cannabis Control Commission.

The Vermont House of Representatives rejected a Senate-passed proposal to
allow cannabis growers to sell directly to consumers.

The Maine House of Representatives rejected a bill to exempt medical
cannabis from sales taxes.

A federal judge denied a request for a temporary injunction against a
Florida law that marijuana legalization and other campaigns say make it
improperly difficult to qualify ballot initiatives.

Minnesota regulators conducted the state’s first marijuana business license
lotteries.

South Dakota regulators filed proposed changes to medical cannabis rules.

Washington State regulators initiated rulemaking on batch tracking of
cannabis plants and measuring marijuana license distance.

The California Legislative Analyst’s Office said that a planned marijuana
tax increase will “reduce the size of the licensed cannabis market.”

Missouri regulators published guidance on permitted activities by marijuana
businesses.

Illinois regulators halted licensing of new recreational marijuana
dispensaries.

The Nebraska Medical Cannabis Commission will hold its first meeting on
Monday.


*— Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug
policy bills in state legislatures and Congress this year. Patreon
supporters pledging at least $25/month get access to our interactive maps,
charts and hearing calendar so they don’t miss any developments.*


*Learn more about our marijuana bill tracker and become a supporter on
Patreon to get access. —*

*/ LOCAL*

Denver, Colorado officials updated a list of neighborhoods with “undue
concentrations” of marijuana businesses.

*/ INTERNATIONAL*

Italian lawmakers approved a bill to ban “cannabis light.”

Indonesian officials arrested foreign nationals, including an Australian,
an Indian and an American, on suspicion of possessing drugs, charges that
could carry the death penalty.

*/ SCIENCE & HEALTH*

A study found “significant reductions in prescription drug claims per
enrollee of $34–42 annually in the small group insurance market following
recreational cannabis legalization.”

A review concluded that “psychedelics,through modulation of serotonin
systems and other neuro-transmitter pathways, show potential in treating sleep
disorders, especially those associated with mental health conditions like
depression, PTSD, and anxiety.”

*/ ADVOCACY, OPINION & ANALYSIS*

The American Psychological Association published an article arguing that
“today’s high-octane cannabis exists in uncharted scientific territory.”

*/ BUSINESS*

Budr Cannabis acquired three dispensaries in Connecticut.

Rubicon Organics Inc. closed its acquisition of a cultivation facility in
Hope, British Columbia, Canada.

Arkansas medical cannabis sales are on track to set a new record this year.

*/ CULTURE*

MMA fighter Kevin Holland said that “until Texas figures out their
legalization of marijuana, it’s kind of hard for me to fight there.”

*Make sure to subscribe to get Marijuana Moment’s daily dispatch in your
inbox.*
Get our daily newsletter.

Email address:

Leave this field empty if you're human:

The post Federal hemp product ban advances in Congress (Newsletter: June 6,
2025) appeared first on Marijuana Moment.